New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsComparePal-AHK vs Tirzepatide

Pal-AHK vs Tirzepatide

Side-by-side comparison of key properties, dosing, and research.

Skin & CosmeticAnti-Aging & Longevity
Pal-AHK
GLP-1 / Weight Loss Agonists
Tirzepatide
Summary
Pal-AHK is the palmitoylated form of the AHK-Cu copper tripeptide, created by attaching a palmitic acid chain to enhance skin penetration and lipid bilayer affinity. The palmitoyl modification significantly improves dermal bioavailability compared to unmodified AHK, making it particularly effective in anti-aging and hair growth formulations.
Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist that produces greater weight loss than semaglutide in head-to-head trials. SURMOUNT-1 trial showed average 21% body weight reduction at 72 weeks at the highest dose. Marketed as Mounjaro (diabetes) and Zepbound (obesity).
Half-Life
Extended (lipid depot effect in stratum corneum)
~5 days
Admin Route
Topical
SubQ
Research
Typical Dose
0.01–0.05% in formulation
2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg
Frequency
Once or twice daily
Once weekly, subcutaneous
Key Benefits
  • Enhanced skin penetration vs. unmodified AHK-Cu
  • Stimulates dermal collagen and elastin production
  • Promotes hair follicle anagen phase
  • Antioxidant and wound healing activity
  • Firming and plumping effect on aging skin
  • Improved bioavailability via lipid bilayer incorporation
  • Average 21% body weight reduction at highest dose (SURMOUNT-1)
  • Superior to semaglutide in head-to-head SURPASS trials
  • Dual GIP/GLP-1 mechanism for enhanced metabolic control
  • Significant reduction in HbA1c for type 2 diabetes
  • Improved cardiovascular risk markers
  • Reduces visceral fat preferentially
  • FDA-approved for T2DM (Mounjaro) and obesity (Zepbound)
  • Weekly dosing
Side Effects
  • Generally well-tolerated
  • Mild irritation at high concentrations in sensitive skin
  • Possible comedogenicity at very high palmitate concentrations (formulation-dependent)
  • Nausea (most common during titration)
  • Vomiting
  • Diarrhea or constipation
  • Abdominal pain
  • +3 more
Stacks With